318 related articles for article (PubMed ID: 28551360)
21. [Chemotherapy and Anticancer Immune Responses].
Harada M
Gan To Kagaku Ryoho; 2016 May; 43(5):571-7. PubMed ID: 27210085
[TBL] [Abstract][Full Text] [Related]
22. Microbiome and host crosstalk: A new paradigm to cancer therapy.
Singh A; Nayak N; Rathi P; Verma D; Sharma R; Chaudhary A; Agarwal A; Tripathi YB; Garg N
Semin Cancer Biol; 2021 May; 70():71-84. PubMed ID: 32479952
[TBL] [Abstract][Full Text] [Related]
23. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.
Galluzzi L; Buqué A; Kepp O; Zitvogel L; Kroemer G
Cancer Cell; 2015 Dec; 28(6):690-714. PubMed ID: 26678337
[TBL] [Abstract][Full Text] [Related]
24. The role of gut microbiota in cancer treatment: friend or foe?
Cheng WY; Wu CY; Yu J
Gut; 2020 Oct; 69(10):1867-1876. PubMed ID: 32759302
[TBL] [Abstract][Full Text] [Related]
25. Exploring the emerging role of the microbiome in cancer immunotherapy.
Fessler J; Matson V; Gajewski TF
J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiome and cancer immunotherapy.
Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
[TBL] [Abstract][Full Text] [Related]
27. Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy.
Daillère R; Derosa L; Bonvalet M; Segata N; Routy B; Gariboldi M; Budinská E; De Vries IJM; Naccarati AG; Zitvogel V; Caldas C; Engstrand L; Loilbl S; Fieschi J; Heinzerling L; Kroemer G; Zitvogel L
Oncoimmunology; 2020 Jun; 9(1):1774298. PubMed ID: 32934879
[TBL] [Abstract][Full Text] [Related]
28. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
Front Immunol; 2021; 12():704942. PubMed ID: 34489956
[TBL] [Abstract][Full Text] [Related]
29. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
[TBL] [Abstract][Full Text] [Related]
30. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
31. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
Wu J; Waxman DJ
Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
[TBL] [Abstract][Full Text] [Related]
32. Immunogenic cell death: A link between gut microbiota and anticancer effects.
Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
[TBL] [Abstract][Full Text] [Related]
33. Microbiome and cancer treatment: Are we ready to apply in clinics?
Chan SL
Prog Mol Biol Transl Sci; 2020; 171():301-308. PubMed ID: 32475526
[TBL] [Abstract][Full Text] [Related]
34. Checkpoint inhibitors in immunotherapy of ovarian cancer.
Wang DH; Guo L; Wu XH
Tumour Biol; 2015 Jan; 36(1):33-9. PubMed ID: 25409618
[TBL] [Abstract][Full Text] [Related]
35. ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents.
Shurin MR; Naiditch H; Gutkin DW; Umansky V; Shurin GV
Curr Med Chem; 2012; 19(12):1792-803. PubMed ID: 22414087
[TBL] [Abstract][Full Text] [Related]
36. Gut Microbiome Modulates Response to Cancer Immunotherapy.
Khan MAW; Ologun G; Arora R; McQuade JL; Wargo JA
Dig Dis Sci; 2020 Mar; 65(3):885-896. PubMed ID: 32067144
[TBL] [Abstract][Full Text] [Related]
37. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.
Pusuluri A; Wu D; Mitragotri S
J Control Release; 2019 Jul; 305():130-154. PubMed ID: 31004668
[TBL] [Abstract][Full Text] [Related]
38. Gut microbes shape response to cancer immunotherapy.
Kaiser J
Science; 2017 Nov; 358(6363):573. PubMed ID: 29097525
[No Abstract] [Full Text] [Related]
39. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
[TBL] [Abstract][Full Text] [Related]
40. Twelve immunotherapy drugs that could cure cancers.
Cheever MA
Immunol Rev; 2008 Apr; 222():357-68. PubMed ID: 18364014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
